Simultaneous Inversion of Particle Size Distribution, Thermal Accommodation Coefficient, and Temperature of In-Flame Soot Aggregates Using Laser-Induced Incandescence.

Measuring the size distribution and temperature of high-temperature dispersed particles, particularly in-flame soot, holds paramount importance across various industries. Laser-induced incandescence (LII) stands out as a potent non-contact diagnostic technology for in-flame soot, although its effectiveness is hindered by uncertainties associated with pre-determined thermal properties. To tackle this challenge, our study proposes a multi-parameter inversion strategy-simultaneous inversion of particle size distribution, thermal accommodation coefficient, and initial temperature of in-flame soot aggregates using time-resolved LII signals. Analyzing the responses of different heat transfer sub-models to temperature rise demonstrates the necessity of incorporating sublimation and thermionic emission for accurately reproducing LII signals of high-temperature dispersed particles. Consequently, we selected a particular LII model for the multi-parameter inversion strategy. Our research reveals that LII-based particle sizing is sensitive to biases in the initial temperature of particles (equivalent to the flame temperature), underscoring the need for the proposed multi-parameter inversion strategy. Numerical results obtained at two typical flame temperatures, 1100 K and 1700 K, illustrate that selecting an appropriate laser fluence enables the simultaneous inversion of particle size distribution, thermal accommodation coefficient, and initial particle temperatures of soot aggregates with high accuracy and confidence using the LII technique.

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities.

Stimulator of interferon genes (STING) is a crucial innate immune sensor responsible for distinguishing pathogens and cytosolic DNA, mediating innate immune signaling pathways to defend the host. Recent studies have revealed additional regulatory functions of STING beyond its innate immune-related activities, including the regulation of cellular metabolism, DNA repair, cellular senescence, autophagy and various cell deaths. These findings highlight the broader implications of STING in cellular physiology beyond its role in innate immunity. Currently, approximately 10 STING agonists have entered the clinical stage. Unlike inhibitors, which have a maximum inhibition limit, agonists have the potential for infinite amplification. STING signaling is a complex process that requires precise regulation of STING to ensure balanced immune responses and prevent detrimental autoinflammation. Recent research on the structural mechanism of STING autoinhibition and its negative regulation by adaptor protein complex 1 (AP-1) provides valuable insights into its different effects under physiological and pathological conditions, offering a new perspective for developing immune regulatory drugs. Herein, we present a comprehensive overview of the regulatory functions and molecular mechanisms of STING beyond innate immune regulation, along with updated details of its structural mechanisms. We discuss the implications of these complex regulations in various diseases, emphasizing the importance and feasibility of targeting the immunity-dependent or immunity-independent functions of STING. Moreover, we highlight the current trend in drug development and key points for clinical research, basic research, and translational research related to STING.

Identification of immune-associated signatures and potential therapeutic targets for pulmonary arterial hypertension.

Pulmonary arterial hypertension (PAH) comprises a heterogeneous group of diseases with diverse aetiologies. It is characterized by increased pulmonary arterial pressure and right ventricular (RV) failure without specific drugs for treatment. Emerging evidence suggests that inflammation and autoimmune disorders are common features across all PAH phenotypes. This provides a novel idea to explore the characteristics of immunological disorders in PAH and identify immune-related genes or biomarkers for specific anti-remodelling regimens. In this study, we integrated three gene expression profiles and performed Gene Ontology (GO) and KEGG pathway analysis. CIBERSORT was utilized to estimate the abundance of tissue-infiltrating immune cells in PAH. The PPI network and machine learning were constructed to identify immune-related hub genes and then evaluate the relationship between hub genes and differential immune cells using ImmucellAI. Additionally, we implemented molecular docking to screen potential small-molecule compounds based on the obtained genes. Our findings demonstrated the density and distribution of infiltrating CD4 T cells in PAH and identified four immune-related genes (ROCK2, ATHL1, HSP90AA1 and ACTR2) as potential targets. We also listed 20 promising molecules, including TDI01953, pemetrexed acid and radotinib, for PAH treatment. These results provide a promising avenue for further research into immunological disorders in PAH and potential novel therapeutic targets.

Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis.

Background: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation and gradual joint degeneration, resulting in function disability. Recently, ferroptosis, a novel form of regulated cell death that involves iron-dependent lipid peroxidation, has been implicated in the pathogenesis of RA. However, the underlying molecular mechanisms and key genes involved in ferroptosis in RA remain largely unknown. Methods: The GSE134420 and GSE77298 datasets were downloaded and DEGs were identified using R software. The DEGs were then mapped to the dataset of 619 ferroptosis-related genes obtained from the GeneCards database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted to investigate the possible biological functions. Protein-protein interaction (PPI) networks were constructed to identify the hub genes. The relationship between hub genes and immune infiltration was estimated using the CIBERSORT algorithms. Gene Set Enrichment Analysis (GSEA) was used to explore the underlying signaling pathways of hub genes. Genome-wide association studies (GWAS) analysis was performed to confirm the pathogenic regions of the hub genes. RcisTarget and Gene-motif ranking databases were used to identify transcription factors (TFs) associated with the hub genes. The miRcode databases were utilized to construct the microRNA (miRNA)-messenger RNA (mRNA) network. Single-cell analysis was utilized to cluster cells and display the expression of hub genes in cell clusters. Finally, the expression and potential mechanism of hub genes were investigated in human and experimental samples. Results: Three hub genes PTGS2, ENO1, and GRN highly associated with ferroptosis were identified. Four pathogenic genes HLA-B, MIF, PSTPIP, TLR1 were identified that were significantly and positively correlated with the expression levels of hub genes. The results of the GSEA showed that the hub genes were significantly enriched in pathways related to immunity, lysosome, phagocytosis and infection. ENO1 and PTGS2 were enriched in the TF-binding motif of cisbp_M5493. The hub genes were validated in experimental and patient samples and highly level of ENO1 expression was found to inhibit ACO1, which reduces ferroptosis in proliferating fibroblast-like synoviocytes (FLS). Conclusion: PTGS2, ENO1 and GRN were identified and validated as potential ferroptosis-related biomarkers. Our work first revealed that ENO1 is highly expressed in RA synovium and that ferroptosis may be regulated by the ENO1-ACO1 axis, advancing the understanding of the underlying ferroptosis-related mechanisms of synovial proliferation and providing potential diagnostic and therapeutic targets for RA.

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis.

Objectives: This study aimed to evaluate the risk of venous thrombosis (VTE) associated with Janus kinase (JAK) inhibitors in patients diagnosed with immune-mediated inflammatory diseases. Methods: We conducted a comprehensive search of PUBMED, Cochrane, and Embase databases for randomized controlled trials evaluating venous thromboembolic incidence after administering JAK inhibitors in patients with immune-mediated inflammatory diseases. The studies were screened according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and a meta-analysis was performed. Results: A total of 16 studies, enrolling 17,242 participants, were included in this review. Four approved doses of JAK inhibitors were administered in the included studies. The meta-analysis revealed no significant difference in the incidence of VTE between patients receiving JAK inhibitors, a placebo, or tumor necrosis factor (TNF) inhibitors (RR 0.72, 95% CI (0.33-1.55); RR 0.94, 95%CI (0.33-2.69)). Subgroup analysis showed a lower risk of VTE with lower doses of JAK inhibitors [RR 0.56, 95%CI (0.36-0.88)]. Compared with the higher dose of tofacitinib, the lower dose was associated with a lower risk of pulmonary embolism [RR 0.37, 95%CI (0.18-0.78)]. Conclusion: Our meta-analysis of randomized controlled trials observed a potential increase in the risk of VTE in patients with immune-mediated inflammatory diseases treated with JAK inhibitors compared to placebo or tumor necrosis factor inhibitors, though statistical significance was not attained. Notably, a higher risk of pulmonary embolism was observed with high doses of tofacitinib. Our findings provide valuable insights for physicians when evaluating the use of JAK inhibitors for patients with immune-mediated inflammatory diseases. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023382544, identifier CRD42023382544.

The challenges and opportunities of αvß3-based therapeutics in cancer: From bench to clinical trials.

Integrins are main cell adhesion receptors serving as linker attaching cells to extracellular matrix (ECM) and bidirectional hubs transmitting biochemical and mechanical signals between cells and their environment. Integrin αvß3 is a critical family member of integrins and interacts with ECM proteins containing RGD tripeptide sequence. Accumulating evidence indicated that the abnormal expression of integrin αvß3 was associated with various tumor progressions, including tumor initiation, sustained tumor growth, distant metastasis, drug resistance development, maintenance of stemness in cancer cells. Therefore, αvß3 has been explored as a therapeutic target in various types of cancers, but there is no αvß3 antagonist approved for human therapy. Targeting-integrin αvß3 therapeutics has been a challenge, but lessons from the past are valuable to the development of innovative targeting approaches. This review systematically summarized the structure, signal transduction, regulatory role in cancer, and drug development history of integrin αvß3, and also provided new insights into αvß3-based therapeutics in cancer from bench to clinical trials, which would contribute to developing effective targeting αvß3 agents for cancer treatment.

Integrated Infrared Radiation Characteristics of Aircraft Skin and the Exhaust Plume.

Infrared radiation (IR) characteristics are important parameters for detecting, identifying, and striking military targets in the context of systematic countermeasures. Accurate calculation of IR characteristics for aircraft is significant for the simulation of war situations and the designation of combat strategy. In this work, integrated IR characteristics of aircraft skin and exhaust plume and their interaction are investigated by considering the reflection based on a bi-directional reflectance distribution function and various influence factors such as solar irradiation, ground reflection, aerodynamic heating, and projection radiation from the background. Combined with infrared emission and reflection characteristics of the skin, omnidirectional IR intensity distributions of 3-5 µm and 8-14 µm at different Mach numbers are obtained. The exhaust plume IR characteristic for different waves and wavebands are also investigated by considering the presence or absence of base and the difference in nozzle inlet temperature. On this basis, integrated IR characteristics between the skin and exhaust plume are investigated. Results show that aircraft IR characteristics of 3-5 µm are concentrated in the exhaust plume and high-temperature skin near the exhaust plume, while the signals of 8-14 µm are concentrated in the skin. The research results are expected to supply guidance for better detection and identification of typical flight targets.

A Parametric Investigation of Corneal Laser Surgery Based on the Multilayer Dynamic Photothermal Model.

Corneal laser surgery is a widely used method for the treatment of ocular myopia, hyperopia, and astigmatism. Although it is a well-established technique, the photothermal properties of the cornea are often overlooked, causing unexpected changes in temperature during laser irradiation. Therefore, there is a need for further investigation of the temperature response of the cornea under laser irradiation. In the present work, a photothermal corneal numerical model is presented, assuming the stratification of the cornea with laser ablation in an uncoagulated layer, a coagulated layer, a dehydrating layer, a dried layer, and a carbonized layer. The modified Pennes' bioheat transfer equation and Lambert-Beer's law are applied to simulate heat transfer in the corneal tissue during laser irradiation. And the corneal dynamic photothermal parameters are considered in the proposed model. The central surface temperature, the boundary and thickness of each layer, and the thermal damage during laser irradiation are investigated. From the model, it was found that in the steady-state process, the thickness of the coagulated layer was 2.6, 14.4, and 52.4 times larger than that of the dehydrating layer, the dried layer, and the carbonized layer, respectively. The thickness of the corneal thermal damage gradually increased, and reached a peak of 0.196 mm at about 18.2 ms. Subsequently, it sharply decreased by 0.01 mm before stabilizing. On this basis, the influence of laser intensity is investigated. The parametric investigation and analysis presented provide a theoretical basis for corneal laser surgery, which can be used to improve our understanding of laser-tissue surgery.